204 related articles for article (PubMed ID: 22088538)
1. Nicotinamide mononucleotide adenylyltransferase 1 gene NMNAT1 regulates neuronal dendrite and axon morphogenesis in vitro.
Zhao H; Zhang JY; Yang ZC; Liu M; Gang BZ; Zhao QJ
Chin Med J (Engl); 2011 Oct; 124(20):3373-7. PubMed ID: 22088538
[TBL] [Abstract][Full Text] [Related]
2. Protection of vincristine-induced neuropathy by WldS expression and the independence of the activity of Nmnat1.
Watanabe M; Tsukiyama T; Hatakeyama S
Neurosci Lett; 2007 Jan; 411(3):228-32. PubMed ID: 17113230
[TBL] [Abstract][Full Text] [Related]
3. Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity.
Yan T; Feng Y; Zheng J; Ge X; Zhang Y; Wu D; Zhao J; Zhai Q
Neurochem Int; 2010 Jan; 56(1):101-6. PubMed ID: 19778564
[TBL] [Abstract][Full Text] [Related]
4. A local mechanism mediates NAD-dependent protection of axon degeneration.
Wang J; Zhai Q; Chen Y; Lin E; Gu W; McBurney MW; He Z
J Cell Biol; 2005 Aug; 170(3):349-55. PubMed ID: 16043516
[TBL] [Abstract][Full Text] [Related]
5. Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration.
Conforti L; Janeckova L; Wagner D; Mazzola F; Cialabrini L; Di Stefano M; Orsomando G; Magni G; Bendotti C; Smyth N; Coleman M
FEBS J; 2011 Aug; 278(15):2666-79. PubMed ID: 21615689
[TBL] [Abstract][Full Text] [Related]
6. NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.
Conforti L; Fang G; Beirowski B; Wang MS; Sorci L; Asress S; Adalbert R; Silva A; Bridge K; Huang XP; Magni G; Glass JD; Coleman MP
Cell Death Differ; 2007 Jan; 14(1):116-27. PubMed ID: 16645633
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide.
Sasaki Y; Vohra BP; Lund FE; Milbrandt J
J Neurosci; 2009 Apr; 29(17):5525-35. PubMed ID: 19403820
[TBL] [Abstract][Full Text] [Related]
8. Identification of a critical site in Wld(s): essential for Nmnat enzyme activity and axon-protective function.
Jia H; Yan T; Feng Y; Zeng C; Shi X; Zhai Q
Neurosci Lett; 2007 Feb; 413(1):46-51. PubMed ID: 17207927
[TBL] [Abstract][Full Text] [Related]
9. Non-syndromic mild mental retardation candidate gene CDKL3 regulates neuronal morphogenesis.
Liu Z; Xu D; Zhao Y; Zheng J
Neurobiol Dis; 2010 Sep; 39(3):242-51. PubMed ID: 20347982
[TBL] [Abstract][Full Text] [Related]
10. Axonal and cell body protection by nicotinamide adenine dinucleotide in tumor necrosis factor-induced optic neuropathy.
Kitaoka Y; Hayashi Y; Kumai T; Takeda H; Munemasa Y; Fujino H; Kitaoka Y; Ueno S; Sadun AA; Lam TT
J Neuropathol Exp Neurol; 2009 Aug; 68(8):915-27. PubMed ID: 19606062
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide Mononucleotide Adenylyltransferase 1 Protects Neural Cells Against Ischemic Injury in Primary Cultured Neuronal Cells and Mouse Brain with Ischemic Stroke Through AMP-Activated Protein Kinase Activation.
Liang J; Wang P; Wei J; Bao C; Han D
Neurochem Res; 2015 Jun; 40(6):1102-10. PubMed ID: 25841561
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Wld(S) or Nmnat2 in mauthner cells by single-cell electroporation delays axon degeneration in live zebrafish.
Feng Y; Yan T; Zheng J; Ge X; Mu Y; Zhang Y; Wu D; Du JL; Zhai Q
J Neurosci Res; 2010 Nov; 88(15):3319-27. PubMed ID: 20857515
[TBL] [Abstract][Full Text] [Related]
13. Axon degeneration: Mechanisms and implications of a distinct program from cell death.
Yan T; Feng Y; Zhai Q
Neurochem Int; 2010 Mar; 56(4):529-34. PubMed ID: 20117162
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy.
Sasaki Y; Araki T; Milbrandt J
J Neurosci; 2006 Aug; 26(33):8484-91. PubMed ID: 16914673
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration.
Yahata N; Yuasa S; Araki T
J Neurosci; 2009 May; 29(19):6276-84. PubMed ID: 19439605
[TBL] [Abstract][Full Text] [Related]
16. Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration.
Avery MA; Sheehan AE; Kerr KS; Wang J; Freeman MR
J Cell Biol; 2009 Feb; 184(4):501-13. PubMed ID: 19237597
[TBL] [Abstract][Full Text] [Related]
17. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo.
Babetto E; Beirowski B; Janeckova L; Brown R; Gilley J; Thomson D; Ribchester RR; Coleman MP
J Neurosci; 2010 Oct; 30(40):13291-304. PubMed ID: 20926655
[TBL] [Abstract][Full Text] [Related]
18. The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration.
Meyer zu Horste G; Miesbach TA; Muller JI; Fledrich R; Stassart RM; Kieseier BC; Coleman MP; Sereda MW
Neurobiol Dis; 2011 Apr; 42(1):1-8. PubMed ID: 21168501
[TBL] [Abstract][Full Text] [Related]
19. TC10β/CDC42 GTPase activating protein is required for the growth of cortical neuron dendrites.
Shen PC; Xu DF; Liu JW; Li K; Lin M; Wang HT; Wang R; Zheng J
Neuroscience; 2011 Dec; 199():589-97. PubMed ID: 21964473
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide mononucleotide adenylyltransferase promotes hypoxic survival by activating the mitochondrial unfolded protein response.
Mao XR; Kaufman DM; Crowder CM
Cell Death Dis; 2016 Feb; 7(2):e2113. PubMed ID: 26913604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
